Cargando…

Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases

Despite recent leaps in modern medicine, progress in the treatment of neurological diseases remains slow. The near impermeable blood-brain barrier (BBB) that prevents the entry of therapeutics into the brain, and the complexity of neurological processes, limits the specificity of potential therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeo, Xin Yi, Cunliffe, Grace, Ho, Roger C., Lee, Su Seong, Jung, Sangyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961788/ https://www.ncbi.nlm.nih.gov/pubmed/35203552 http://dx.doi.org/10.3390/biomedicines10020343

Ejemplares similares

Editorial: Global excellence in brain disease mechanisms: Asia & Australasia
por: Cunliffe, Grace, et al.
Publicado: (2023)

Alternative Pharmacological Strategies for the Treatment of Alzheimer’s Disease: Focus on Neuromodulator Function
por: Cunliffe, Grace, et al.
Publicado: (2022)

Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010)

Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease
por: Holanda, Victor A. D., et al.
Publicado: (2021)

The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders
por: Song, You-Hyang, et al.
Publicado: (2021)

Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases
por: Wu, Haijian, et al.
Publicado: (2015)

Neuropeptides Involved in Facial Nerve Regeneration
por: Kim, Inhyeok, et al.
Publicado: (2021)

Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases?
por: Tan, Li Yang, et al.
Publicado: (2021)

Emergence of taurine as a therapeutic agent for neurological disorders
por: Jangra, Ashok, et al.
Publicado: (2023)

Direct and Indirect Antimicrobial Activities of Neuropeptides and their Therapeutic Potential
por: Augustyniak, Daria, et al.
Publicado: (2012)

Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma
por: Loong, Herbert H, et al.
Publicado: (2014)

Neuro faces of beneficial T cells: essential in brain, impaired in aging and neurological diseases, and activated functionally by neurotransmitters and neuropeptides
por: Levite, Mia
Publicado: (2022)

Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders
por: Balakrishnan, Rengasamy, et al.
Publicado: (2022)

Macrocycles and Supramolecules as Antioxidants: Excellent Scaffolds for Development of Potential Therapeutic Agents
por: Lee, Jung-Seop, et al.
Publicado: (2020)

The therapeutic potential of bone marrow‐derived macrophages in neurological diseases
por: Zhou, Kai, et al.
Publicado: (2022)

Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases
por: Kong, Yew Rong, et al.
Publicado: (2021)

Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies
por: Sánchez, Manuel Lisardo, et al.
Publicado: (2023)

Demystifying the Neuroprotective Role of Neuropeptides in Parkinson’s Disease: A Newfangled and Eloquent Therapeutic Perspective
por: Behl, Tapan, et al.
Publicado: (2022)

Potential Therapeutic Effects of Neurotrophins for Acute and Chronic Neurological Diseases
por: Cai, Junying, et al.
Publicado: (2014)

Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease
por: Chen, Xin-Yi, et al.
Publicado: (2019)

L-serine: Neurological Implications and Therapeutic Potential
por: Phone Myint, Soe Maung Maung, et al.
Publicado: (2023)

Effects of Neuropeptide Y on Stem Cells and Their Potential Applications in Disease Therapy
por: Peng, Song, et al.
Publicado: (2017)

Acid-sensing ion channels: potential therapeutic targets for neurologic diseases
por: Liu, Sha, et al.
Publicado: (2015)

Connexins and Pannexins: Important Players in Neurodevelopment, Neurological Diseases, and Potential Therapeutics
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022)

Astaxanthin: A Potential Therapeutic Agent in Cardiovascular Disease
por: Fassett, Robert G., et al.
Publicado: (2011)

Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
por: Moors, Tim E., et al.
Publicado: (2017)

Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases
por: Aljohani, Maher M., et al.
Publicado: (2022)

Neuropeptide GPCRs in Neuroendocrinology
por: Vaudry, Hubert, et al.
Publicado: (2014)

Neuropeptides at the crossroad of fear and hunger: a special focus on neuropeptide Y
por: Comeras, Lucas B., et al.
Publicado: (2019)

Mesenchymal Stromal Cells Perspective: New Potential Therapeutic for the Treatment of Neurological Diseases
por: Mukai, Takeo, et al.
Publicado: (2021)

Roles of Neuropeptides in Sleep–Wake Regulation
por: Shen, Yi-Chen, et al.
Publicado: (2022)

The therapeutic potential of triptolide and celastrol in neurological diseases
por: Cui, Yueran, et al.
Publicado: (2022)

RNA-based therapeutics for neurological diseases
por: Anthony, Karen
Publicado: (2022)

Mesenchymal Stem/Stromal Cell-Mediated Mitochondrial Transfer and the Therapeutic Potential in Treatment of Neurological Diseases
por: Han, Deqiang, et al.
Publicado: (2020)

Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
por: Giacoppo, Sabrina, et al.
Publicado: (2014)

Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
por: Mishra, Awanish, et al.
Publicado: (2021)

Overview of Salvia miltiorrhiza as a Potential Therapeutic Agent for Various Diseases: An Update on Efficacy and Mechanisms of Action
por: Jung, Inyong, et al.
Publicado: (2020)

The Role of Neuropeptides in Pathogenesis of Dry Dye
por: Hwang, Daniel Duck-Jin, et al.
Publicado: (2021)

Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent
por: Li, Jingjing, et al.
Publicado: (2020)

GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders
por: Martínez-Bailén, Macarena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5brc54sva5tu46siamm27c6v4i